The COX2-PGE2-PKA axis suppresses antiviral immunity by inhibiting mtDNA-dependent STING activation
Year: 2026
Type: article
Abstract: SUMMARY The innate immune cGAS-STING pathway is activated by cytosolic double-stranded DNA (dsDNA) to induce type I interferon (IFN) response, which is essential for mounting the antiviral response. However, STING activation during viral infection is often insufficient to achieve complete viral clearance, suggesting the existence of additional mechanisms that evade its activity. Here, we identified COX2/PGE 2 as a negative regulator of STING activation, particularly in response to arising cytosolic mitochondrial DNA (mtDNA) generated during HSV-1 infection. Mechanistically, PGE 2 , through the EP4-cAMP-PKA axis, induces mitophagy to remove defective mitochondria and hence prevent the accumulation of immunostimulatory cytosolic mtDNA, thereby dampening STING-mediated type I IFN and antiviral response. Furthermore, we identified STOML2 as a downstream target of PKA that connects mitochondrial quality control with the regulation of innate immune signaling. Together, our findings establish the COX2/PGE 2 /PKA axis as a negative regulator of mtDNA-STING signaling that may be targeted to potentiate STING-mediated type I IFN and innate immunity. Abstract Figure Graphical abstract
Source: Cell Reports
Authors: Pham Thuy Tien Vo, Julien Cicero, Zichen Wang, Hiroyuki Hakozaki, Thomas S. Hoang, Sendi Rafael Adame-Garcia, Dana J. Ramms, Kuniaki Sato, Erica Stevenson, Yuan Zhou, Katie Fan, Juliette A. Bokor, Vasiliya Kril, Cara Schiavon, Scott B. Biering, Danielle L. Swaney, Nevan J. Krogan, Johannes Schöneberg, Uri Manor, J. Silvio Gutkind
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $5,620
Awards: Research Center for Cancer Systems Biology: Cancer Cell Map Initiative, Targeting Signaling Vulnerabilities for Oral Cancer Prevention, Modeling and Analysis of the Spatio-Temporal Dynamics of the Mitochondrial Network, UCSD Cancer Center Training Program in Drug Development, The Cancer Cell Map Initiative v2.0, Reprogramming the Tumor Immune Microenvironment with Chemokines to Potentiate Immune Oncology Treatments in Oral Cancer
OpenAlex ID: W7222615316
